Compile Data Set for Download or QSAR
Report error Found 64 Enz. Inhib. hit(s) with all data for entry = 9866
TargetGalectin-1(Human)
Galecto Biotech

US Patent
LigandPNGBDBM494857(US10988502, Example 25 | 3-Bromo-4-chlorophenyl 3-...)
Affinity DataKd:  440nMAssay Description:Compounds for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the interaction between gal...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/1/2021
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM494849(US10988502, Example 17 | 3,4,5-Trichlorophenyl 3-d...)
Affinity DataKd:  1.30E+3nMAssay Description:Compounds for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the interaction between gal...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/1/2021
Entry Details
Go to US Patent

TargetGalectin-1(Human)
Galecto Biotech

US Patent
LigandPNGBDBM494850(US10988502, Example 18 | 3,4-Dichlorophenyl 3-deox...)
Affinity DataKd:  240nMAssay Description:Compounds for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the interaction between gal...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/1/2021
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM494850(US10988502, Example 18 | 3,4-Dichlorophenyl 3-deox...)
Affinity DataKd:  4.10E+3nMAssay Description:Compounds for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the interaction between gal...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/1/2021
Entry Details
Go to US Patent

TargetGalectin-1(Human)
Galecto Biotech

US Patent
LigandPNGBDBM494851(US10988502, Example 19 | 3,4,5-Trichlorophenyl 3-d...)
Affinity DataKd:  350nMAssay Description:Compounds for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the interaction between gal...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/1/2021
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM494851(US10988502, Example 19 | 3,4,5-Trichlorophenyl 3-d...)
Affinity DataKd:  4.40E+3nMAssay Description:Compounds for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the interaction between gal...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/1/2021
Entry Details
Go to US Patent

TargetGalectin-1(Human)
Galecto Biotech

US Patent
LigandPNGBDBM494852(US10988502, Example 20 | 5-Bromopyrdin-3-yl 3-deox...)
Affinity DataKd:  550nMAssay Description:Compounds for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the interaction between gal...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/1/2021
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM494852(US10988502, Example 20 | 5-Bromopyrdin-3-yl 3-deox...)
Affinity DataKd:  4.60E+3nMAssay Description:Compounds for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the interaction between gal...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/1/2021
Entry Details
Go to US Patent

TargetGalectin-1(Human)
Galecto Biotech

US Patent
LigandPNGBDBM494853(US10988502, Example 21 | 5-Chloropyridin-3-yl 3-de...)
Affinity DataKd:  220nMAssay Description:Compounds for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the interaction between gal...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/1/2021
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM494853(US10988502, Example 21 | 5-Chloropyridin-3-yl 3-de...)
Affinity DataKd:  1.80E+3nMAssay Description:Compounds for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the interaction between gal...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/1/2021
Entry Details
Go to US Patent

TargetGalectin-1(Human)
Galecto Biotech

US Patent
LigandPNGBDBM494854(US10988502, Example 22 | 5-Bromo-2-cyano-pyridine-...)
Affinity DataKd:  200nMAssay Description:Compounds for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the interaction between gal...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/1/2021
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM494854(US10988502, Example 22 | 5-Bromo-2-cyano-pyridine-...)
Affinity DataKd:  1.20E+3nMAssay Description:Compounds for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the interaction between gal...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/1/2021
Entry Details
Go to US Patent

TargetGalectin-1(Human)
Galecto Biotech

US Patent
LigandPNGBDBM494855(US10988502, Example 23 | 5-Chloro-6-cyano-pyridine...)
Affinity DataKd:  440nMAssay Description:Compounds for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the interaction between gal...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/1/2021
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM494855(US10988502, Example 23 | 5-Chloro-6-cyano-pyridine...)
Affinity DataKd:  4.40E+3nMAssay Description:Compounds for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the interaction between gal...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/1/2021
Entry Details
Go to US Patent

TargetGalectin-1(Human)
Galecto Biotech

US Patent
LigandPNGBDBM494856(US10988502, Example 24 | 3,5-Dichlorophenyl 3-deox...)
Affinity DataKd:  340nMAssay Description:Compounds for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the interaction between gal...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/1/2021
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM494856(US10988502, Example 24 | 3,5-Dichlorophenyl 3-deox...)
Affinity DataKd:  1.60E+3nMAssay Description:Compounds for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the interaction between gal...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/1/2021
Entry Details
Go to US Patent

TargetGalectin-1(Human)
Galecto Biotech

US Patent
LigandPNGBDBM494849(US10988502, Example 17 | 3,4,5-Trichlorophenyl 3-d...)
Affinity DataKd:  610nMAssay Description:Compounds for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the interaction between gal...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/1/2021
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM494857(US10988502, Example 25 | 3-Bromo-4-chlorophenyl 3-...)
Affinity DataKd:  4.40E+3nMAssay Description:Compounds for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the interaction between gal...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/1/2021
Entry Details
Go to US Patent

TargetGalectin-1(Human)
Galecto Biotech

US Patent
LigandPNGBDBM494858(US10988502, Example 26 | 5-Bromo-6-trifluoromethyl...)
Affinity DataKd:  310nMAssay Description:Compounds for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the interaction between gal...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/1/2021
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM494858(US10988502, Example 26 | 5-Bromo-6-trifluoromethyl...)
Affinity DataKd:  2.00E+3nMAssay Description:Compounds for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the interaction between gal...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/1/2021
Entry Details
Go to US Patent

TargetGalectin-1(Human)
Galecto Biotech

US Patent
LigandPNGBDBM494859(US10988502, Example 27 | 3-Bromo-4-fluoro-phenyl 3...)
Affinity DataKd:  490nMAssay Description:Compounds for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the interaction between gal...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/1/2021
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM494859(US10988502, Example 27 | 3-Bromo-4-fluoro-phenyl 3...)
Affinity DataKd:  4.70E+3nMAssay Description:Compounds for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the interaction between gal...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/1/2021
Entry Details
Go to US Patent

TargetGalectin-1(Human)
Galecto Biotech

US Patent
LigandPNGBDBM494860(US10988502, Example 28 | 2,5-Dichlorophenyl 3-deox...)
Affinity DataKd:  910nMAssay Description:Compounds for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the interaction between gal...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/1/2021
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM494860(US10988502, Example 28 | 2,5-Dichlorophenyl 3-deox...)
Affinity DataKd:  8.20E+3nMAssay Description:Compounds for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the interaction between gal...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/1/2021
Entry Details
Go to US Patent

TargetGalectin-1(Human)
Galecto Biotech

US Patent
LigandPNGBDBM494861(US10988502, Example 29 | 3,4-dichlorophenyl 3-deox...)
Affinity DataKd:  150nMAssay Description:Compounds for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the interaction between gal...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/1/2021
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM494861(US10988502, Example 29 | 3,4-dichlorophenyl 3-deox...)
Affinity DataKd:  810nMAssay Description:Compounds for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the interaction between gal...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/1/2021
Entry Details
Go to US Patent

TargetGalectin-1(Human)
Galecto Biotech

US Patent
LigandPNGBDBM494862(US10988502, Example 30 | 3,4-Dichlorophenyl 3-deox...)
Affinity DataKd:  400nMAssay Description:Compounds for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the interaction between gal...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/1/2021
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM494862(US10988502, Example 30 | 3,4-Dichlorophenyl 3-deox...)
Affinity DataKd:  1.60E+3nMAssay Description:Compounds for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the interaction between gal...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/1/2021
Entry Details
Go to US Patent

TargetGalectin-1(Human)
Galecto Biotech

US Patent
LigandPNGBDBM494863(US10988502, Example 31 | 3,4-Dichlorophenyl 3-deox...)
Affinity DataKd:  120nMAssay Description:Compounds for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the interaction between gal...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/1/2021
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM494863(US10988502, Example 31 | 3,4-Dichlorophenyl 3-deox...)
Affinity DataKd:  460nMAssay Description:Compounds for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the interaction between gal...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/1/2021
Entry Details
Go to US Patent

TargetGalectin-1(Human)
Galecto Biotech

US Patent
LigandPNGBDBM494864(US10988502, Example 32 | 3,4-Dichlorophenyl 3-deox...)
Affinity DataKd:  790nMAssay Description:Compounds for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the interaction between gal...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/1/2021
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM494864(US10988502, Example 32 | 3,4-Dichlorophenyl 3-deox...)
Affinity DataKd:  210nMAssay Description:Compounds for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the interaction between gal...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/1/2021
Entry Details
Go to US Patent

TargetGalectin-1(Human)
Galecto Biotech

US Patent
LigandPNGBDBM494618(US10988502, Example 9 | 3,4-Dichlorophenyl 3-deoxy...)
Affinity DataKd:  550nMAssay Description:Compounds for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the interaction between gal...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/1/2021
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM494606(US10988502, Example 1 | 3,4-Dichlorophenyl 3-deoxy...)
Affinity DataKd:  2.60E+3nMAssay Description:Compounds for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the interaction between gal...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/1/2021
Entry Details
Go to US Patent

TargetGalectin-1(Human)
Galecto Biotech

US Patent
LigandPNGBDBM494607(US10988502, Example 2 | 2-Chloro-5-fluoro-benzonit...)
Affinity DataKd:  190nMAssay Description:Compounds for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the interaction between gal...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/1/2021
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM494607(US10988502, Example 2 | 2-Chloro-5-fluoro-benzonit...)
Affinity DataKd:  1.95E+3nMAssay Description:Compounds for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the interaction between gal...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/1/2021
Entry Details
Go to US Patent

TargetGalectin-1(Human)
Galecto Biotech

US Patent
LigandPNGBDBM494608(US10988502, Example 3 | 5-Bromopyridin-3-yl 3-deox...)
Affinity DataKd:  680nMAssay Description:Compounds for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the interaction between gal...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/1/2021
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM494608(US10988502, Example 3 | 5-Bromopyridin-3-yl 3-deox...)
Affinity DataKd:  1.70E+3nMAssay Description:Compounds for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the interaction between gal...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/1/2021
Entry Details
Go to US Patent

TargetGalectin-1(Human)
Galecto Biotech

US Patent
LigandPNGBDBM494609(US10988502, Example 4 | 5-Bromo-6-trifluoromethyl-...)
Affinity DataKd:  380nMAssay Description:Compounds for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the interaction between gal...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/1/2021
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM494609(US10988502, Example 4 | 5-Bromo-6-trifluoromethyl-...)
Affinity DataKd:  1.20E+3nMAssay Description:Compounds for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the interaction between gal...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/1/2021
Entry Details
Go to US Patent

TargetGalectin-1(Human)
Galecto Biotech

US Patent
LigandPNGBDBM494610(US10988502, Example 5 | 3,5-Dichloro-4-fluoro-phen...)
Affinity DataKd:  280nMAssay Description:Compounds for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the interaction between gal...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/1/2021
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM494610(US10988502, Example 5 | 3,5-Dichloro-4-fluoro-phen...)
Affinity DataKd:  1.00E+4nMAssay Description:Compounds for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the interaction between gal...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/1/2021
Entry Details
Go to US Patent

TargetGalectin-1(Human)
Galecto Biotech

US Patent
LigandPNGBDBM494613(US10988502, Example 6 | 3,4-Dichlorophenyl 3-deoxy...)
Affinity DataKd:  240nMAssay Description:Compounds for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the interaction between gal...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/1/2021
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM494613(US10988502, Example 6 | 3,4-Dichlorophenyl 3-deoxy...)
Affinity DataKd:  690nMAssay Description:Compounds for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the interaction between gal...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/1/2021
Entry Details
Go to US Patent

TargetGalectin-1(Human)
Galecto Biotech

US Patent
LigandPNGBDBM494614(US10988502, Example 7 | 5-Bromopyridin-3-yl 3-deox...)
Affinity DataKd:  450nMAssay Description:Compounds for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the interaction between gal...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/1/2021
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM494614(US10988502, Example 7 | 5-Bromopyridin-3-yl 3-deox...)
Affinity DataKd:  1.25E+3nMAssay Description:Compounds for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the interaction between gal...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/1/2021
Entry Details
Go to US Patent

TargetGalectin-1(Human)
Galecto Biotech

US Patent
LigandPNGBDBM494616(US10988502, Example 8 | 3,5-Dichloro-4-fluoro-phen...)
Affinity DataKd:  920nMAssay Description:Compounds for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the interaction between gal...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/1/2021
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM494616(US10988502, Example 8 | 3,5-Dichloro-4-fluoro-phen...)
Affinity DataKd:  2.30E+3nMAssay Description:Compounds for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the interaction between gal...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/1/2021
Entry Details
Go to US Patent

TargetGalectin-1(Human)
Galecto Biotech

US Patent
LigandPNGBDBM494606(US10988502, Example 1 | 3,4-Dichlorophenyl 3-deoxy...)
Affinity DataKd:  140nMAssay Description:Compounds for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the interaction between gal...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/1/2021
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM494618(US10988502, Example 9 | 3,4-Dichlorophenyl 3-deoxy...)
Affinity DataKd:  970nMAssay Description:Compounds for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the interaction between gal...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/1/2021
Entry Details
Go to US Patent

Displayed 1 to 50 (of 64 total ) | Next | Last >>
Jump to: